Back to FDA Applications sponsored by PARKE DAVIS

FDA Drug Application 021129 by PARKE DAVIS

Application Number021129
Application Type New Drug Application
Sponsor ApplicantPARKE DAVIS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP03/2/2000N8528000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-129_Neurontin.cfm 5/6/2004
AP03/2/2000N19007000   http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100192.htm 2/1/2008
AP03/2/2000N26657000   http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229208.pdf 10/13/2010
AP09/19/2000SCM       
AP010/12/2000SE88533005   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-216_20-235S15_20-882S2_21-129S5_Neurontin.cfm 5/6/2004
AP04/26/2001SCM       
AP01/18/2002SCS       
AP01/30/2002SLR2940009   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21129s9ltr.pdf 1/30/2002
AP08/15/2002SE89261010   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20235se8-023,20882se8-009,21129se8-010ltr.pdf 6/10/2004
AP010/24/2002SCM       
AP012/19/2002SCS       
AP02/18/2005SLR11150016   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/20235s029,20882s015,21129s016ltr.pdf 2/23/2005
AP02/18/2005SLR11174016   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20235s029,20882s015,21129s016lbl.pdf 2/23/2005
AP05/3/2006SLR14053020   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020235s035, 020882s021, 021129s020LTR.pdf 5/5/2006
AP03/1/2011SLR28088022   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020235s036,020882s022,021129s022lbl.pdf 3/4/2011
AP03/1/2011SLR28110022   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020235s036,020882s022,021129s022ltr.pdf 3/7/2011
AP04/23/2009SLR22347027   http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020235s041,020882s028,021129s027lbl.pdf 4/28/2009
AP04/23/2009SLR22385027   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021129s027ltr.pdf 5/1/2009
AP010/11/2010SLR26624029   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021129s029lbl.pdf 10/11/2010
AP010/11/2010SLR26665029   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020235s043,020882s030,021129s029ltr.pdf 10/13/2010
AP08/10/2011SLR29742033   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020235s050,020882s035,021129s033lbl.pdf 8/11/2011
AP08/10/2011SLR29757033   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020235s050,020882s035,021129s033ltr.pdf 8/12/2011
AP05/1/2013SLR35963035   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020235Orig1s054,s055,s056,020882Orig1s038,s039,s040,021129Orig1s035,s036,s037ltr.pdf 5/7/2013
AP05/1/2013SLR36002035   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020235s054s055s056,020882s038s039s040,021129s035s036s037lbl.pdf 5/9/2013
AP05/1/2013SLR35964036   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020235Orig1s054,s055,s056,020882Orig1s038,s039,s040,021129Orig1s035,s036,s037ltr.pdf 5/7/2013
AP05/1/2013SLR36003036   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020235s054s055s056,020882s038s039s040,021129s035s036s037lbl.pdf 5/9/2013
AP05/1/2013SLR35965037   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020235Orig1s054,s055,s056,020882Orig1s038,s039,s040,021129Orig1s035,s036,s037ltr.pdf 5/7/2013
AP05/1/2013SLR36004037   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020235s054s055s056,020882s038s039s040,021129s035s036s037lbl.pdf 5/9/2013
AP07/18/2013SCM       
AP08/18/2014SLR40283039   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020235Orig1s057,020882Orig1s041,021129Orig1s039ltr.pdf 8/20/2014
AP08/18/2014SLR40285039   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020235s057,020882s041,021129s039lbl.pdf 8/20/2014
AP04/15/2014SCM       
AP09/14/2015SLR43899042   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020235Orig1s060,020882s043,021129Orig1s042ltr.pdf 9/17/2015
AP09/14/2015SLR43970042   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020235s060,020882s043,021129s042lbl.pdf 9/23/2015
AP04/21/2015SLR42630043   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020235Orig1s061,020882Orig1s044,021129Orig1s043ltr.pdf 4/22/2015
AP04/21/2015SLR42665043   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020235s061,020882s044,021129s043lbl.pdf 4/27/2015




Back to FDA Applications sponsored by PARKE DAVIS